Recursion Pharmaceuticals Inc Cl A
(RXRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RXRX | HRMY | MESO | ||
| Company | Recursion Pharmaceuticals Inc Cl A | Harmony Biosciences Holdings Inc | Mesoblast Ltd ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 3.74 | 36.74 | 15.74 | ||
| High | 4.02 | 37.54 | 16.07 | ||
| Low | 3.69 | 36.17 | 15.55 | ||
| Latest | 3.98 | 37.27 | 15.95 | ||
| Change | +0.42 | +0.86 | -0.13 | ||
| % Change | +11.80% | +2.36% | -0.81% | ||
| Volume | 26,273,000 | 567,500 | 283,900 | ||
| 20-Day Average Volume | 22,503,961 | 625,070 | 226,605 | ||
| Previous Close | 3.56 | 36.41 | 16.08 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 4.45 | 36.95 | 17.84 | ||
| 20-Day Raw Stochastic | 25.88% | 54.87% | 6.72% | ||
| 20-Day Relative Strength | 43.26 | 52.30 | 40.31 | ||
| Weighted Alpha | -53.53 | +6.46 | -21.03 | ||
| Today's Opinion | 100% Sell | 40% Buy | 8% Buy | ||
| Previous Opinion | 88% Sell | 24% Buy | 8% Buy | ||
| Last Month's Opinion | 64% Sell | 88% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.01% since 01/30/26 | +2.05% since 01/30/26 | -7.54% since 01/30/26 | ||
| Low | 3.54 on 02/05/26 | 36.17 on 02/06/26 | 15.55 on 02/06/26 | ||
| High | 4.28 on 02/03/26 | 38.37 on 02/03/26 | 17.61 on 02/03/26 | ||
| 1-Month | |||||
| %Chg | -12.53% since 01/06/26 | +1.41% since 01/06/26 | -14.11% since 01/06/26 | ||
| Low | 3.54 on 02/05/26 | 34.68 on 01/13/26 | 15.55 on 02/06/26 | ||
| High | 5.24 on 01/22/26 | 39.40 on 01/12/26 | 21.50 on 01/09/26 | ||
| 3-Month | |||||
| %Chg | -13.85% since 11/06/25 | +20.46% since 11/06/25 | +6.83% since 11/06/25 | ||
| Low | 3.54 on 02/05/26 | 30.55 on 11/07/25 | 14.10 on 11/07/25 | ||
| High | 5.24 on 01/22/26 | 40.87 on 12/15/25 | 21.50 on 01/09/26 | ||
| 6-Month | |||||
| %Chg | -27.37% since 08/06/25 | +7.50% since 08/06/25 | +1.85% since 08/06/25 | ||
| Low | 3.54 on 02/05/26 | 25.52 on 10/20/25 | 12.66 on 09/03/25 | ||
| High | 7.18 on 10/20/25 | 40.87 on 12/15/25 | 21.50 on 01/09/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,068,955 | 2,146,603 | 2,058,028 | ||
| Shares Outstanding, K | 519,838 | 57,596 | 129,030 | ||
| Annual Sales | 58,840,000 | 714,730,000 | 17,200,000 | ||
| Annual Net Income | -463,660,000 | 145,490,000 | -102,140,000 | ||
| Last Quarter Sales | 5,180,000 | 239,460,000 | 1,930,000 | ||
| Last Quarter Net Income | -162,250,000 | 50,870,000 | -21,920,000 | ||
| 60-Month Beta | 0.95 | 0.84 | 2.15 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.36 on 11/05/25 | 0.87 on 11/04/25 | N/A on 09/06/19 | ||
| Latest Earnings Date | 02/27/26 | 02/24/26 | 09/03/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 11.45 | 0.00 | ||